Is Increasing Antibiotic Resistance Driving Bacteriophage Therapy Closer to Being a Reality?

Posted 14 August 2017 By Max Sherman

placeholder+image This article reviews the history of bacteriophage discovery, biology, and potential medical uses, and discusses therapeutic pros and cons compared to and potentially replacing antibiotics due to increasing antibiotic resistance. The article also highlights the future of phage therapy and the need for more scientific investigation and clinical trials prior to approval for human use and the possible patenting and regulatory issues impacting bacteriophage development. The US Food and Drug Administration (FDA) recently covered issues related to bacteriophage development during a workshop in July 2017.

Share this article:

Categories: Biologics and biotechnology, Features, FDA

Tags: Bacteriophage, Phage, Antimicrobial Resistance

Regulatory Exchange: Latest Updates From the Community